GUILLERMO
LÓPEZ VIVANCO
Forscher bis um 2022
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clínico Universitario Lozano Blesa (11)
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428
2014
-
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: The BRCA1-RAP80 Expression Customization (BREC) studies
Annals of Oncology, Vol. 25, Núm. 11, pp. 2147-2155
2013
-
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study
Thrombosis Research, Vol. 132, Núm. 6, pp. 666-670
2012
2010
-
Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients
Lung Cancer, Vol. 68, Núm. 3, pp. 491-497
2009
-
Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
PLoS ONE, Vol. 4, Núm. 5
-
Screening for epidermal growth factor receptor mutations in lung cancer
New England Journal of Medicine, Vol. 361, Núm. 10, pp. 958-967
2006
-
The place of targeted therapies in the management of non-small cell bronchial carcinoma: Molecular markers as predictors of tumor response and survival in lung cancer
Revue des Maladies Respiratoires, Vol. 23, Núm. 5 C3
2004
-
Single nucleotide polymorphisms and outcome in docetaxel - Cisplatin-treated advanced non-small-cell lung cancer
Annals of Oncology, Vol. 15, Núm. 8, pp. 1194-1203
2003
-
Marcadores tumorales y reactantes de fase aguda en el diagnóstico del cáncer de páncreas
Gastroenterologia y Hepatologia, Vol. 26, Núm. 10, pp. 624-629
1998
-
Serum proteolytic activities and antiproteases in human colorectal carcinoma
Journal of Physiology and Biochemistry, Vol. 54, Núm. 1, pp. 9-14